Ingredients & Safety

IPA Europe: Probiotics Could Save EU Health Systems Over €10bn Per Year

 
• By 

Just a 1% improvement thanks to probiotic use in areas like antibiotic‑associated diarrhea, respiratory tract health, oral health, women’s health, lactose digestion, and mental wellbeing could generate significant savings for Europe's strained health systems.

Opella Partners With Verb Biotics To Create ‘Next-Generation’ Microbiome Solutions

 
• By 

With its new parntership with Colorado's Verb Biotics, Opella says it wants to create “clinically proven gut health solutions, ready for real life.”

Japan Restricts Access To Eight OTC Medicines To Prevent Misuse

 
• By 

Japan is tightening access to eight widely used OTC ingredients from May 2026 to curb youth misuse, a move broadly accepted by industry but expected to constrain online availability due to strict face‑to‑face or video‑verified sales requirements.

CBD Used By One In Five Brits, Mostly For Wellbeing, Mental Health And Pain

 
• By 

Nearly one in five UK adults have used CBD in the past year, mainly for wellbeing, mental health and pain, with many users reporting reliance, strong brand‑trust considerations and growing concerns about unauthorized products.


Opella Study Finds ‘Significant Variation’ In Probiotic Quality In India

 
• By 

Only Opella’s own Enterogermina brand was found by a company-funded study to be contamination-free, to contain the claimed content, and show resistance to all tested antibiotics.

BMJ Study: No Clear Link Between In Utero Paracetamol Exposure And Autism, ADHD

 
• By 

The studies reviewed by BMJ researchers failed to account for the fact that the association between in utero exposure to paracetamol and autism and ADHD in childhood “might be driven by familial genetic and environmental factors.”

Brits Becoming More Deficient In Key Nutrients, Pointing To Need For Supplementation

 
• By 

Brits are consuming insufficient amounts of vitamin D, riboflavin, folate, iron, calcium, potassium, iodine, selenium and omega 3, according to a recently published study. Consumer health companies can help by providing affordable supplements with easy to understand health claims.

Norway Decides Against Tighter Restrictions For Ibuprofen

 
• By 

Norway's Medical Products Agency has rejected claims that misuse of OTC ibuprofen is linked to its availability for purchase in outlets other than pharmacies.


OTC Analgesic Pollutants In Scope Of EU Water Strategy Agreed By Council

 
• By 

EU legislation aimed at controlling at source emerging pollutants such commonly used OTC analgesics like ibuprofen and diclofenac and “forever chemicals” like perfluoroalkyl and polyfluoroalkyl substances (PFAS) edges closer to adoption.

EU VMS Max Levels Should Aim At ‘Optimal Health’ Not Just Deficiency

 
• By 

“The European Commission’s work on harmonizing maximum levels of vitamins and minerals should fully reflect the positive role that food supplements can play in safely and effectively addressing micronutrient gaps,” insists Food Supplements Europe chair Peter Loosen.

European Regulators And Industry Stand By Paracetamol Safety After US Warning

 
• By 

EMA and MHRA among European regulators reiterating the safety of paracetamol use by pregnant women following news FDA will require OTCs to carry label warning.

EFSA Suggests 2mg Daily CBD Limit, Cannot Establish Safe Intake For Under 25s

 
• By 

EFSA is consulting on a provisional CBD safe dose of 2mg for a 70kg adult and has stated that the safety of CBD cannot be established for individuals under 25 years of age, pregnant or lactating women, and those on existing medications.


Just One More Step Before The First Legal UK CBD Food Supplements

 
• By 

UK CBD food supplement applications from Chanelle McCoy, Cannaray Brands and the European Industrial Hemp Association pass FSA's safety assessment stage and are now out for consultation. After that, only government approval stands in their way, with five years exclusivity the icing on the cake.

German Quaternary Wastewater Treatment Cost Estimates ‘Not Realistic’

 
• By 

Updating wastewater treatment facilities in Germany will cost almost three times more than the German Association of Local Public Utilities (VKU) has predicted, according to a Pharma Deutschland analysis.

GSCF: ‘No One Size Fits All’ Solution To Tricky Sustainable Blister Pack Challenge

 
• By 

A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.

EFSA: ‘A Dose Of Estragole Without A Harmful Effect Cannot Be Established’

 
• By 

Dietary supplements containing estragole may have to be removed from the European Union market due to carcinogenic risk, according to a draft scientific opinion from EFSA that is currently out for consultation.


Urban Wastewater Directive: AESGP Requests Intervention In EFPIA’s Legal Action

 
• By 

AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.

Gardenia Blue, OrangeOvation, StellarYellow Latest Natural Pivots In US Food Color Market

 

FDA’s fourth approval in past two months for color derived from natural sources to use in foods is Gardenia Blue Interest Group’s color additive petition for gardenia blue. Lycored launches StellarYellow and C Clear as alternatives for synthetic dyes yellow Nos. 5 and 6 and OrangeOvation C Clear for

House OMUFA Reauthorization Bill Takes On Clarifying Standards For Tests To Meet GRASE

 

Health Subcommittee will discuss reauthorizing OMUFA during a hearing on how to “maintain and improve” the public health workforce and rural health as well as access to OTC medicines.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By 

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.